In the brain, ITM2B interacts with AβPP (Amyloid β Precursor Protein) acting as an inhibitor of Amyloid β (Aβ) oligomerization12–14, a major component of amyloid plaques in AD and AD-like diseases. Here, APP is linked to Alzheimer disease.